Product
PD-1 Combined With Pyrotinib
1 clinical trial
1 indication
Indication
NSCLCClinical trial
the Effectiveness and Safety Study on PD-1 Combined With Pyrotinib for First-line Chemotherapy Failed HER2 Insertion Mutation Advanced Non-small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2023-12-30